Reset Pharmaceuticals
Biotechnology Research
3 employees
- Employees
- 3
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Reset Pharmaceuticals Overview
- Website
- www.resetpharma.com
- Industry
- Biotechnology Research
- Employees
- 3
- Funding
- 11.1M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Reset Pharmaceuticals
Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. The company’s lead program focuses on psilocybin with psychotherapy for patients with cancer related demoralization, anxiety and depression. Reset Pharma has established a highly experienced biotech development team and has a Scientific Advisory Board of leading experts in psychiatry, oncology and psychedelics.
Reset Pharmaceuticals Contact Details
- People in AeroLeads
- 2
- With contact data
- 2
- Email contacts
- 2
- 100.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Reset Pharmaceuticals Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Greg Mckee | Founder & Chief Executive Officer | San Diego County, California, United States |
Email
Phone
|
| Jan-Anders Karlsson | Managing Director at Cja Medical | Greater London, England, United Kingdom |
Email
|
Compare Similar Companies to Reset Pharmaceuticals
Compass Pathways
Mental Health Care
MindMed
Biotechnology Research
AdhereTech
Technology, Information And Internet
Gilgamesh Pharmaceuticals
Pharmaceutical Manufacturing
Delix Therapeutics
Biotechnology Research
Transcend Therapeutics
Biotechnology Research
PsyMed Ventures
Venture Capital And Private Equity Principals
WiseLayer | makers of Accruals.ai
Software Development
Seelos Therapeutics, Inc.
Biotechnology
Freedom Biosciences
Biotechnology Research